Other News To Note
Friday, June 1, 2012
Medigene AG, of Martinsried, Germany, said genital warts treatment Veregen obtained market approval in Serbia. The drug will be launched there in the second half of this year.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.